These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 9738464
41. Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. Scherer PE, Lisanti MP, Baldini G, Sargiacomo M, Mastick CC, Lodish HF. J Cell Biol; 1994 Dec; 127(5):1233-43. PubMed ID: 7962086 [Abstract] [Full Text] [Related]
42. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex. Galbiati F, Volonte D, Minetti C, Chu JB, Lisanti MP. J Biol Chem; 1999 Sep 03; 274(36):25632-41. PubMed ID: 10464299 [Abstract] [Full Text] [Related]
43. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP. J Biol Chem; 1997 Mar 07; 272(10):6525-33. PubMed ID: 9045678 [Abstract] [Full Text] [Related]
44. Reduction of caveolin 1 gene expression in lung carcinoma cell lines. Racine C, Bélanger M, Hirabayashi H, Boucher M, Chakir J, Couet J. Biochem Biophys Res Commun; 1999 Feb 24; 255(3):580-6. PubMed ID: 10049753 [Abstract] [Full Text] [Related]
45. Formation of intracellular vesicles within the Gram+ Lactococcus lactis induced by the overexpression of Caveolin-1β. Flourieusse A, Bourgeois P, Schenckbecher E, Palvair J, Legrand D, Labbé C, Bescond T, Avoscan L, Orlowski S, Rouleau A, Frelet-Barrand A. Microb Cell Fact; 2022 Nov 17; 21(1):239. PubMed ID: 36384643 [Abstract] [Full Text] [Related]
46. Identification of filamin as a novel ligand for caveolin-1: evidence for the organization of caveolin-1-associated membrane domains by the actin cytoskeleton. Stahlhut M, van Deurs B. Mol Biol Cell; 2000 Jan 17; 11(1):325-37. PubMed ID: 10637311 [Abstract] [Full Text] [Related]
47. Caveolae and caveolin isoforms in rat peritoneal macrophages. Kiss AL, Turi A, Müller N, Kántor O, Botos E. Micron; 2002 Jan 17; 33(1):75-93. PubMed ID: 11473817 [Abstract] [Full Text] [Related]
48. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Fra AM, Williamson E, Simons K, Parton RG. Proc Natl Acad Sci U S A; 1995 Sep 12; 92(19):8655-9. PubMed ID: 7567992 [Abstract] [Full Text] [Related]
49. Crowded little caves: structure and function of caveolae. Schlegel A, Volonte D, Engelman JA, Galbiati F, Mehta P, Zhang XL, Scherer PE, Lisanti MP. Cell Signal; 1998 Jul 12; 10(7):457-63. PubMed ID: 9754713 [Abstract] [Full Text] [Related]
50. Visualization of caveolin-1, a caveolar marker protein, in living cells using green fluorescent protein (GFP) chimeras. The subcellular distribution of caveolin-1 is modulated by cell-cell contact. Volonte D, Galbiati F, Lisanti MP. FEBS Lett; 1999 Feb 26; 445(2-3):431-9. PubMed ID: 10094502 [Abstract] [Full Text] [Related]
51. The caveolin proteins. Williams TM, Lisanti MP. Genome Biol; 2004 Feb 26; 5(3):214. PubMed ID: 15003112 [Abstract] [Full Text] [Related]
52. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Glenney JR, Soppet D. Proc Natl Acad Sci U S A; 1992 Nov 01; 89(21):10517-21. PubMed ID: 1279683 [Abstract] [Full Text] [Related]
53. Caveolae in human and murine osteoblasts. Solomon KR, Adolphson LD, Wank DA, McHugh KP, Hauschka PV. J Bone Miner Res; 2000 Dec 01; 15(12):2391-401. PubMed ID: 11127204 [Abstract] [Full Text] [Related]
54. Regulation of cAMP-mediated signal transduction via interaction of caveolins with the catalytic subunit of protein kinase A. Razani B, Rubin CS, Lisanti MP. J Biol Chem; 1999 Sep 10; 274(37):26353-60. PubMed ID: 10473592 [Abstract] [Full Text] [Related]
55. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Scherer PE, Okamoto T, Chun M, Nishimoto I, Lodish HF, Lisanti MP. Proc Natl Acad Sci U S A; 1996 Jan 09; 93(1):131-5. PubMed ID: 8552590 [Abstract] [Full Text] [Related]
56. Caveolin-1 interacts with the insulin receptor and can differentially modulate insulin signaling in transfected Cos-7 cells and rat adipose cells. Nystrom FH, Chen H, Cong LN, Li Y, Quon MJ. Mol Endocrinol; 1999 Dec 09; 13(12):2013-24. PubMed ID: 10598578 [Abstract] [Full Text] [Related]
57. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease. Hnasko R, Lisanti MP. Mol Interv; 2003 Dec 09; 3(8):445-64. PubMed ID: 14993453 [Abstract] [Full Text] [Related]
58. Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia. Lee H, Park DS, Razani B, Russell RG, Pestell RG, Lisanti MP. Am J Pathol; 2002 Oct 09; 161(4):1357-69. PubMed ID: 12368209 [Abstract] [Full Text] [Related]
59. Molecular characterization of caveolin association with the Golgi complex: identification of a cis-Golgi targeting domain in the caveolin molecule. Luetterforst R, Stang E, Zorzi N, Carozzi A, Way M, Parton RG. J Cell Biol; 1999 Jun 28; 145(7):1443-59. PubMed ID: 10385524 [Abstract] [Full Text] [Related]
60. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, Kohtz DS, Lisanti MP. FEBS Lett; 1998 May 29; 428(3):205-11. PubMed ID: 9654135 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]